[心肌梗死后的药物治疗] - Suppr

Suppr

超能文献

[Pharmacotherapy after cardiac infarction].

作者信息

Darius H, Meyer J

机构信息

II. Medizinische Klinik & Poliklinik, Johannes Gutenberg-Universität, Langenbeckstrasse 1, 55101 Mainz.

出版信息

Internist (Berl). 2001 May;42(5):699-712. doi: 10.1007/s001080050811.

DOI:10.1007/s001080050811

PMID:11400577

Abstract

摘要

相似文献

[Pharmacotherapy after cardiac infarction].

Internist (Berl). 2001 May;42(5):699-712. doi: 10.1007/s001080050811.

[Secondary prevention after cardiac infarct; therapeutic efficiency--cost-benefit ratio].

Internist (Berl). 2001 May;42(5):713-9. doi: 10.1007/s001080050812.

Adjunctive treatment in patients treated with thrombolytic therapy.

Heart. 2004 May;90(5):581-8. doi: 10.1136/hrt.2003.019877.

Do All Patients Need β-Blockers After a Heart Attack?

JAMA. 2018 Mar 6;319(9):853-855. doi: 10.1001/jama.2018.0107.

Secondary prevention following myocardial infarction: a clinical update.

Br J Gen Pract. 2018 Mar;68(668):151-152. doi: 10.3399/bjgp18X695261.

Management of acute coronary syndromes.

Am J Respir Crit Care Med. 2001 Sep 15;164(6):917-22. doi: 10.1164/ajrccm.164.6.2101047.

Primary prevention of myocardial infarction: putting the evidence to use.

Arch Intern Med. 2010 Aug 9;170(15):1381-2. doi: 10.1001/archinternmed.2010.266.

Pharmacotherapy following myocardial infarction--a review of current treatment practices.

Expert Opin Pharmacother. 2000 Sep;1(6):1105-16. doi: 10.1517/14656566.1.6.1105.

Medical management after myocardial infarction.

Future Cardiol. 2019 May;15(3):135-138. doi: 10.2217/fca-2019-0014. Epub 2019 May 31.

Advances in the medical management of acute coronary syndromes.

J Thromb Thrombolysis. 1999 Apr;7(2):171-89. doi: 10.1023/a:1008841721975.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Pharmacotherapy after cardiac infarction].

Internist (Berl). 2001 May;42(5):699-712. doi: 10.1007/s001080050811.

[Secondary prevention after cardiac infarct; therapeutic efficiency--cost-benefit ratio].

Internist (Berl). 2001 May;42(5):713-9. doi: 10.1007/s001080050812.

Adjunctive treatment in patients treated with thrombolytic therapy.

Heart. 2004 May;90(5):581-8. doi: 10.1136/hrt.2003.019877.

Do All Patients Need β-Blockers After a Heart Attack?

JAMA. 2018 Mar 6;319(9):853-855. doi: 10.1001/jama.2018.0107.

Secondary prevention following myocardial infarction: a clinical update.

Br J Gen Pract. 2018 Mar;68(668):151-152. doi: 10.3399/bjgp18X695261.

Management of acute coronary syndromes.

Am J Respir Crit Care Med. 2001 Sep 15;164(6):917-22. doi: 10.1164/ajrccm.164.6.2101047.

Primary prevention of myocardial infarction: putting the evidence to use.

Arch Intern Med. 2010 Aug 9;170(15):1381-2. doi: 10.1001/archinternmed.2010.266.

Pharmacotherapy following myocardial infarction--a review of current treatment practices.

Expert Opin Pharmacother. 2000 Sep;1(6):1105-16. doi: 10.1517/14656566.1.6.1105.

Medical management after myocardial infarction.

Future Cardiol. 2019 May;15(3):135-138. doi: 10.2217/fca-2019-0014. Epub 2019 May 31.

Advances in the medical management of acute coronary syndromes.

J Thromb Thrombolysis. 1999 Apr;7(2):171-89. doi: 10.1023/a:1008841721975.